Scarica l'app Stockscreener
14.00
10.67%
1.35
Dopo l'orario di chiusura:
14.00
Precedente Chiudi:
$12.65
Aprire:
$12.35
Volume 24 ore:
303.41K
Relative Volume:
1.28
Capitalizzazione di mercato:
$201.92M
Reddito:
$6.39M
Utile/perdita netta:
$-117.26M
Rapporto P/E:
-1.1217
EPS:
-12.4807
Flusso di cassa netto:
$-79.08M
1 W Prestazione:
+28.32%
1M Prestazione:
+21.74%
6M Prestazione:
-69.38%
1 anno Prestazione:
-19.26%
Intervallo 1D:
$12.04
$14.36
Intervallo di 1 settimana:
$9.8995
$14.36
Portata 52W:
$5.2044
$55.89
Korro Bio Inc Stock (KRRO) Company Profile
Nome
Korro Bio Inc
Settore
Industria
Telefono
617-468-1999
Indirizzo
60 FIRST STREET, CAMBRIDGE
Compare KRRO vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
14.00 | 201.92M | 6.39M | -117.26M | -79.08M | -12.48 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2026-02-17 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2026-01-29 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2026-01-29 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2026-01-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2026-01-28 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2026-01-28 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-11-13 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-11-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2025-11-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-11-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-11-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-11-13 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| 2025-11-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Iniziato | Chardan Capital Markets | Buy |
| 2025-01-10 | Iniziato | Oppenheimer | Outperform |
| 2024-10-21 | Iniziato | Raymond James | Strong Buy |
| 2024-08-14 | Iniziato | William Blair | Outperform |
| 2024-03-28 | Reiterato | H.C. Wainwright | Buy |
| 2024-02-27 | Iniziato | BMO Capital Markets | Outperform |
| 2023-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-10 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Downgrade | Cowen | Outperform → Market Perform |
| 2021-09-22 | Downgrade | Goldman | Buy → Neutral |
| 2021-01-27 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Iniziato | B. Riley Securities | Buy |
| 2020-07-14 | Iniziato | Oppenheimer | Outperform |
| 2020-05-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Iniziato | Cowen | Outperform |
| 2019-10-28 | Iniziato | Goldman | Buy |
| 2019-10-28 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Korro Bio Inc Borsa (KRRO) Ultime notizie
KRRO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Lynx1 Capital buys Korro Bio (KRRO) shares worth $5512 - Investing.com
Lynx1 and Weston Nichols report 1.54M shares in Korro Bio (NASDAQ: KRRO) - Stock Titan
Lynx1 fund tied to Weston Nichols adds Korro Bio (KRRO) position - Stock Titan
Fund linked to Korro Bio (KRRO) reports 1.54M shares on Form 3 - Stock Titan
Earnings Update: Can Korro Bio Inc be recession proof2026 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn
KRRO Price Today: Korro Bio, Inc. Stock Price, Quote & Chart - MEXC Exchange
Investment Recap: Should you avoid Korro Bio Inc stock right now2026 Volume & Community Consensus Trade Signals - baoquankhu1.vn
Breakout Watch: Will Korro Bio Inc benefit from green energy policiesAnalyst Upgrade & AI Forecast Swing Trade Picks - baoquankhu1.vn
JPMorgan Chase & Co. Buys 196,079 Shares of Korro Bio, Inc. $KRRO - MarketBeat
Korro Bio, Inc. (NASDAQ:KRRO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Aug Shorts: What is the next catalyst for Korro Bio Inc2026 Historical Comparison & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Trading Recap: Can Korro Bio Inc disrupt its industry2026 Support & Resistance & Risk Managed Investment Signals - baoquankhu1.vn
Vanguard (KRRO) reports zero beneficial ownership after realignment - Stock Titan
Korro Bio stock gains after tough 2025new drug candidate, analyst upgrades boost outlook - MSN
[EFFECT] Korro Bio, Inc. SEC Filing - Stock Titan
Form 424B5 Korro Bio Inc For: 20 March By Investing.com - Investing.com Canada
Aug Decliners: What is the next catalyst for Korro Bio IncPortfolio Return Report & Verified Swing Trading Watchlists - baoquankhu1.vn
Form 424B5 Korro Bio Inc For: 20 March - Investing.com
Korro Bio (NASDAQ: KRRO) registers 7.65M shares for resale after $85M private placement - Stock Titan
Energy Moves: Will Korro Bio Inc stock hit new highs in YEAR2026 Geopolitical Influence & High Return Trade Opportunity Guides - baoquankhu1.vn
Korro Bio, Inc. (KRRO) reports Q4 loss, lags revenue estimates - MSN
Venrock entities cap ownership at 9.99% in Korro Bio (KRRO) Schedule 13G - Stock Titan
Korro Bio raises $85 million in private equity financing By Investing.com - Investing.com Nigeria
KRRO SEC FilingsKorro Bio, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Korro Bio Stock Gains After Tough 2025New Drug Candidate, Analyst Upgrades Boost Outlook - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
RBC Capital Keeps Their Hold Rating on Korro Bio (KRRO) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Korro Bio (KRRO) and Pharming Group (PHAR) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Sagimet Biosciences, Inc. Class A (SGMT) and Bristol-Myers Squibb (BMY) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Korro Bio (KRRO), Oruka Therapeutics (ORKA) and Gilead Sciences (GILD) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT) - The Globe and Mail
Korro Bio (KRRO) Losses Of US$117.3 Million Test Bullish Narratives On Profitability - simplywall.st
Korro Bio (KRRO) sellers register 7.65M common shares after $85M private placement - Stock Titan
Korro Bio (NASDAQ:KRRO) Rating Increased to Outperform at Raymond James Financial - MarketBeat
Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence By Investing.com - Investing.com South Africa
Cantor Fitzgerald raises Korro Bio stock price target on UCD confidence - Investing.com Canada
Raymond James Upgrades Korro Bio to Outperform From Market Perform, Price Target is $23 - marketscreener.com
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot - Investing.com Nigeria
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot By Investing.com - Investing.com Australia
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - The Manila Times
Insider Buying: New Enterprise Associates 17, L.P. Acquires Addi - GuruFocus
Korro Bio, Inc. (KRRO) Reports Q4 Loss, Lags Revenue Estimates - sharewise.com
Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com
Korro Bio investor buys $2.3 million in KRRO stock By Investing.com - Investing.com
Advancing Genetic Medicines with RNA Editing: Inside the OPERA Platform and Therapeutic Strategies - Minichart
Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million - Investing.com
Baskett Forest buys Korro Bio (KRRO) shares worth $2.3 million By Investing.com - Investing.com South Africa
Nea 17 buys Korro Bio (KRRO) shares worth $2.3 million By Investing.com - Investing.com South Africa
Korro Bio (KRRO) major holder adds stock and pre-funded warrants in March 2026 buy - Stock Titan
NEA 17 fund boosts Korro Bio (KRRO) stake with stock and pre-funded warrants - Stock Titan
Korro Bio Inc Azioni (KRRO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):